Literature DB >> 8510008

Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.

D L Nelson1, V L Lucaites, J E Audia, J S Nissen, D B Wainscott.   

Abstract

Species differences in the recognition of a series of ergolines by the 5-hydroxytryptamine2 (5-HT2, serotonin2) receptor were investigated in four species, the rat, pig, squirrel monkey and human. In pig frontal cortical membranes the initial studies showed that the ergolines gave shallow displacement curves against [3H]ketanserin binding. The component of [3H]ketanserin binding having low affinity for the ergolines was determined to be the result of [3H]ketanserin binding to alpha-1 adrenergic receptors. Thus, in all subsequent assays prazosin was used to mask [3H]ketanserin binding to alpha-1 adrenergic receptors. Examination of a series of ergolines revealed a distinct pattern in the species selectivity. Compounds that were unsubstituted at the N1 position of the ergoline nucleus showed higher affinity for the pig, squirrel monkey and human 5-HT2 receptors than for the rat. Conversely, compounds that had an N1-isopropyl substituent showed higher affinity for the rat receptor compared to the pig, squirrel monkey and human 5-HT2 receptors. For example, LY53857, a widely used 5-HT2 antagonist, has an isopropyl substituent at position N1 of the ergoline nucleus and exhibited a 4- to 5-fold higher affinity for the rat 5-HT2 receptor, whereas its N1-unsubstituted homologue, LY86057, had more than 10-fold higher affinity for the pig, squirrel monkey and human 5-HT2 receptors. Similar results were seen with three additional ergoline pairs, each having different substituents at the C8 position compared to LY53857. Even an N1-substitution on LY53857 as small as a methyl group, LY108742, resulted in the compound having higher affinity for the rat 5-HT2 receptor compared to the other species.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510008

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.

Authors:  Jacob M Hooker; Sung Won Kim; Achim T Reibel; David Alexoff; Youwen Xu; Colleen Shea
Journal:  Bioorg Med Chem       Date:  2010-04-20       Impact factor: 3.641

2.  Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice.

Authors:  John P Dougherty; Vincent J Aloyo
Journal:  Psychopharmacology (Berl)       Date:  2011-02-22       Impact factor: 4.530

3.  Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.

Authors:  R H Porter; K R Benwell; H Lamb; C S Malcolm; N H Allen; D F Revell; D R Adams; M J Sheardown
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

4.  Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.

Authors:  Landon M Klein; Nicholas V Cozzi; Paul F Daley; Simon D Brandt; Adam L Halberstadt
Journal:  Neuropharmacology       Date:  2018-02-27       Impact factor: 5.250

5.  [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand.

Authors:  M P Johnson; B W Siegel; A A Carr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

6.  The role of serotonergic receptors in the effects of mu opioids in squirrel monkeys responding under a titration procedure.

Authors:  K R Powell; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

7.  A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor.

Authors:  James J Chambers; David E Nichols
Journal:  J Comput Aided Mol Des       Date:  2002-07       Impact factor: 3.686

8.  The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.

Authors:  D W Bonhaus; C Bach; A DeSouza; F H Salazar; B D Matsuoka; P Zuppan; H W Chan; R M Eglen
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

9.  Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.

Authors:  Clinton E Canal; Tania Cordova-Sintjago; Yue Liu; Myong S Kim; Drake Morgan; Raymond G Booth
Journal:  J Pharmacol Exp Ther       Date:  2013-09-30       Impact factor: 4.030

10.  Structural basis for molecular recognition at serotonin receptors.

Authors:  Chong Wang; Yi Jiang; Jinming Ma; Huixian Wu; Daniel Wacker; Vsevolod Katritch; Gye Won Han; Wei Liu; Xi-Ping Huang; Eyal Vardy; John D McCorvy; Xiang Gao; X Edward Zhou; Karsten Melcher; Chenghai Zhang; Fang Bai; Huaiyu Yang; Linlin Yang; Hualiang Jiang; Bryan L Roth; Vadim Cherezov; Raymond C Stevens; H Eric Xu
Journal:  Science       Date:  2013-03-21       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.